{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,2]],"date-time":"2026-10-02T22:27:13Z","timestamp":1790980033406,"version":"4.1.0"},"reference-count":119,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2008,3,1]],"date-time":"2008-03-01T00:00:00Z","timestamp":1204329600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,10,16]],"date-time":"2020-10-16T00:00:00Z","timestamp":1602806400000},"content-version":"vor","delay-in-days":4612,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Journal of Lipid Research"],"published-print":{"date-parts":[[2008,3]]},"DOI":"10.1194\/jlr.r800001-jlr200","type":"journal-article","created":{"date-parts":[[2008,1,8]],"date-time":"2008-01-08T23:04:24Z","timestamp":1199833464000},"page":"499-509","source":"Crossref","is-referenced-by-count":183,"title":["Thematic Review Series: Skin Lipids. Peroxisome proliferator-activated receptors and liver X receptors in epidermal biology"],"prefix":"10.1016","volume":"49","author":[{"given":"Matthias","family":"Schmuth","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yan J.","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sandrine","family":"Dubrac","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter M.","family":"Elias","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kenneth R.","family":"Feingold","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1194\/jlr.R800001-JLR200_bib1","doi-asserted-by":"crossref","first-page":"1899","DOI":"10.1056\/NEJMra041320","article-title":"Psoriasis","volume":"352","author":"Schon","year":"2005","journal-title":"N. Engl. J. Med."},{"key":"10.1194\/jlr.R800001-JLR200_bib2","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1016\/S0733-8635(05)70376-4","article-title":"Population-based epidemiologic study of psoriasis with emphasis on quality of life assessment","volume":"14","author":"Koo","year":"1996","journal-title":"Dermatol. Clin."},{"key":"10.1194\/jlr.R800001-JLR200_bib3","doi-asserted-by":"crossref","first-page":"121","DOI":"10.2174\/1568010043343958","article-title":"Epidemiology of psoriasis","volume":"3","author":"Naldi","year":"2004","journal-title":"Curr. Drug Targets."},{"key":"10.1194\/jlr.R800001-JLR200_bib4","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/S0140-6736(03)12193-9","article-title":"Atopic dermatitis","volume":"361","author":"Leung","year":"2003","journal-title":"Lancet."},{"key":"10.1194\/jlr.R800001-JLR200_bib5","doi-asserted-by":"crossref","first-page":"1406","DOI":"10.1016\/j.jaci.2007.08.067","article-title":"Toward a major risk factor for atopic eczema: meta-analysis of filaggrin polymorphism data","volume":"120","author":"Baurecht","year":"2007","journal-title":"J. Allergy Clin. Immunol."},{"key":"10.1194\/jlr.R800001-JLR200_bib6","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1038\/ng1767","article-title":"Common loss-of-function variants of the epidermal barrier protein filaggrin are a major predisposing factor for atopic dermatitis","volume":"38","author":"Palmer","year":"2006","journal-title":"Nat. Genet."},{"key":"10.1194\/jlr.R800001-JLR200_bib7","doi-asserted-by":"crossref","first-page":"650","DOI":"10.1038\/ng2020","article-title":"Comprehensive analysis of the gene encoding filaggrin uncovers prevalent and rare mutations in ichthyosis vulgaris and atopic eczema","volume":"39","author":"Sandilands","year":"2007","journal-title":"Nat. Genet."},{"key":"10.1194\/jlr.R800001-JLR200_bib8","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1093\/rheumatology\/keh423","article-title":"Treatment of active psoriatic arthritis with the PPARgamma ligand pioglitazone: an open-label pilot study","volume":"44","author":"Bongartz","year":"2005","journal-title":"Rheumatology (Oxford)."},{"key":"10.1194\/jlr.R800001-JLR200_bib9","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1001\/archderm.136.5.609","article-title":"Troglitazone improves psoriasis and normalizes models of proliferative skin disease: ligands for peroxisome proliferator-activated receptor-gamma inhibit keratinocyte proliferation","volume":"136","author":"Ellis","year":"2000","journal-title":"Arch. Dermatol."},{"key":"10.1194\/jlr.R800001-JLR200_bib10","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1111\/j.1365-2133.2005.06369.x","article-title":"Pioglitazone: a promising therapy for psoriasis","volume":"152","author":"Robertshaw","year":"2005","journal-title":"Br. J. Dermatol."},{"key":"10.1194\/jlr.R800001-JLR200_bib11","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1007\/s00403-004-0480-5","article-title":"Alpha-lipoic acid-based PPARgamma agonists for treating inflammatory skin diseases","volume":"296","author":"Venkatraman","year":"2004","journal-title":"Arch. Dermatol. Res."},{"key":"10.1194\/jlr.R800001-JLR200_bib12","doi-asserted-by":"crossref","first-page":"1453","DOI":"10.1517\/13543784.15.11.1453","article-title":"Thiazolidinediones: potential as therapeutics for psoriasis and perhaps other hyperproliferative skin disease","volume":"15","author":"Varani","year":"2006","journal-title":"Expert Opin. Investig. Drugs."},{"key":"10.1194\/jlr.R800001-JLR200_bib13","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1055\/s-2007-961808","article-title":"Nuclear hormone receptors in human skin","volume":"39","author":"Schmuth","year":"2007","journal-title":"Horm. Metab. Res."},{"key":"10.1194\/jlr.R800001-JLR200_bib14","doi-asserted-by":"crossref","first-page":"43","DOI":"10.3322\/canjclin.57.1.43","article-title":"Cancer statistics, 2007","volume":"57","author":"Jemal","year":"2007","journal-title":"CA Cancer J. Clin."},{"issue":"Suppl. 61","key":"10.1194\/jlr.R800001-JLR200_bib15","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1046\/j.1365-2133.146.s61.2.x","article-title":"The epidemiology of skin cancer","volume":"146","author":"Diepgen","year":"2002","journal-title":"Br. J. Dermatol."},{"key":"10.1194\/jlr.R800001-JLR200_bib16","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1038\/sj.jidsymp.5650007","article-title":"Functions of the peroxisome proliferator-activated receptor (PPAR) alpha and beta in skin homeostasis, epithelial repair, and morphogenesis","volume":"11","author":"Icre","year":"2006","journal-title":"J. Invest. Dermatol."},{"key":"10.1194\/jlr.R800001-JLR200_bib17","doi-asserted-by":"crossref","first-page":"991","DOI":"10.1016\/j.bbalip.2007.02.004","article-title":"Peroxisome proliferator-activated receptors (PPARs) in skin health, repair and disease","volume":"1771","author":"Michalik","year":"2007","journal-title":"Biochim. Biophys. Acta."},{"key":"10.1194\/jlr.R800001-JLR200_bib18","article-title":"Sebaceous gland lipids: friend or foe?","volume":"48","author":"Smith","year":"2007","journal-title":"J. Lipid Res."},{"key":"10.1194\/jlr.R800001-JLR200_bib19","doi-asserted-by":"crossref","first-page":"789","DOI":"10.1016\/j.cell.2006.06.049","article-title":"Anatomical profiling of nuclear receptor expression reveals a hierarchical transcriptional network","volume":"126","author":"Bookout","year":"2006","journal-title":"Cell."},{"key":"10.1194\/jlr.R800001-JLR200_bib20","doi-asserted-by":"crossref","first-page":"1305","DOI":"10.1002\/art.20104","article-title":"Disruption of transforming growth factor beta signaling and profibrotic responses in normal skin fibroblasts by peroxisome proliferator-activated receptor gamma","volume":"50","author":"Ghosh","year":"2004","journal-title":"Arthritis Rheum."},{"key":"10.1194\/jlr.R800001-JLR200_bib21","first-page":"506","article-title":"Induction of human liver X receptor alpha gene expression via an autoregulatory loop mechanism","volume":"16","author":"Li","year":"2002","journal-title":"Mol. Endocrinol."},{"key":"10.1194\/jlr.R800001-JLR200_bib22","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1007\/s00109-005-0715-8","article-title":"Enzymes involved in the biosynthesis of leukotriene B4 and prostaglandin E2 are active in sebaceous glands","volume":"84","author":"Alestas","year":"2006","journal-title":"J. Mol. Med."},{"key":"10.1194\/jlr.R800001-JLR200_bib23","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1210\/endo.137.1.8536636","article-title":"Differential expression of peroxisome proliferator-activated receptors (PPARs): tissue distribution of PPAR-alpha, -beta, and -gamma in the adult rat","volume":"137","author":"Braissant","year":"1996","journal-title":"Endocrinology."},{"key":"10.1194\/jlr.R800001-JLR200_bib24","doi-asserted-by":"crossref","first-page":"766","DOI":"10.1111\/j.1365-2133.2004.06171.x","article-title":"Peroxisome proliferator-activated receptor and farnesoid X receptor ligands differentially regulate sebaceous differentiation in human sebaceous gland organ cultures in vitro","volume":"151","author":"Downie","year":"2004","journal-title":"Br. J. Dermatol."},{"key":"10.1194\/jlr.R800001-JLR200_bib25","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1006\/mgme.2001.3242","article-title":"Limited cooperation between peroxisome proliferator-activated receptors and retinoid X receptor agonists in sebocyte growth and development","volume":"74","author":"Kim","year":"2001","journal-title":"Mol. Genet. Metab."},{"key":"10.1194\/jlr.R800001-JLR200_bib26","doi-asserted-by":"crossref","first-page":"844","DOI":"10.1111\/j.1600-0625.2007.00612.x","article-title":"Characterization of liver X receptor expression and function in human skin and the pilosebaceous unit","volume":"16","author":"Russell","year":"2007","journal-title":"Exp. Dermatol."},{"key":"10.1194\/jlr.R800001-JLR200_bib27","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1080\/000155500459240","article-title":"Expression of peroxisome proliferator activated receptors (PPARs) in human hair follicles and PPAR alpha involvement in hair growth","volume":"80","author":"Billoni","year":"2000","journal-title":"Acta Derm. Venereol."},{"key":"10.1194\/jlr.R800001-JLR200_bib28","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1016\/j.cell.2006.07.036","article-title":"Tcf3 governs stem cell features and represses cell fate determination in skin","volume":"127","author":"Nguyen","year":"2006","journal-title":"Cell."},{"key":"10.1194\/jlr.R800001-JLR200_bib29","doi-asserted-by":"crossref","first-page":"2748","DOI":"10.1210\/endo.139.6.6049","article-title":"Differential expression of peroxisome proliferator-activated receptor-alpha, -beta, and -gamma during rat embryonic development","volume":"139","author":"Braissant","year":"1998","journal-title":"Endocrinology."},{"key":"10.1194\/jlr.R800001-JLR200_bib30","doi-asserted-by":"crossref","first-page":"799","DOI":"10.1083\/jcb.200011148","article-title":"Impaired skin wound healing in peroxisome proliferator-activated receptor (PPAR)alpha and PPARbeta mutant mice","volume":"154","author":"Michalik","year":"2001","journal-title":"J. Cell Biol."},{"key":"10.1194\/jlr.R800001-JLR200_bib31","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/S0303-7207(98)00214-7","article-title":"Correlation between expression of peroxisome proliferator-activated receptor beta and squamous differentiation in epidermal and tracheobronchial epithelial cells","volume":"147","author":"Matsuura","year":"1999","journal-title":"Mol. Cell. Endocrinol."},{"key":"10.1194\/jlr.R800001-JLR200_bib32","doi-asserted-by":"crossref","first-page":"1116","DOI":"10.1046\/j.1523-1747.1998.00439.x","article-title":"Differential expression of peroxisome proliferator-activated receptor subtypes during the differentiation of human keratinocytes","volume":"111","author":"Rivier","year":"1998","journal-title":"J. Invest. Dermatol."},{"key":"10.1194\/jlr.R800001-JLR200_bib33","doi-asserted-by":"crossref","first-page":"702","DOI":"10.1046\/j.1523-1747.2001.01329.x","article-title":"Modulation of keratinocyte gene expression and differentiation by PPAR-selective ligands and tetradecylthioacetic acid","volume":"116","author":"Westergaard","year":"2001","journal-title":"J. Invest. Dermatol."},{"key":"10.1194\/jlr.R800001-JLR200_bib34","doi-asserted-by":"crossref","first-page":"788","DOI":"10.1046\/j.1523-1747.1999.00743.x","article-title":"Fetal epidermal differentiation and barrier development in vivo is accelerated by nuclear hormone receptor activators","volume":"113","author":"Hanley","year":"1999","journal-title":"J. Invest. Dermatol."},{"key":"10.1194\/jlr.R800001-JLR200_bib35","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1046\/j.0022-202x.2001.01628.x","article-title":"Oxysterol stimulation of epidermal differentiation is mediated by liver X receptor-beta in murine epidermis","volume":"118","author":"Komuves","year":"2002","journal-title":"J. Invest. Dermatol."},{"key":"10.1194\/jlr.R800001-JLR200_bib36","doi-asserted-by":"crossref","first-page":"5295","DOI":"10.4049\/jimmunol.170.10.5295","article-title":"Peroxisome proliferator-activated receptor gamma inhibits the migration of dendritic cells: consequences for the immune response","volume":"170","author":"Angeli","year":"2003","journal-title":"J. Immunol."},{"key":"10.1194\/jlr.R800001-JLR200_bib37","doi-asserted-by":"crossref","first-page":"4362","DOI":"10.4049\/jimmunol.178.7.4362","article-title":"Peroxisome proliferator-activated receptor-alpha activation inhibits Langerhans cell function","volume":"178","author":"Dubrac","year":"2007","journal-title":"J. Immunol."},{"key":"10.1194\/jlr.R800001-JLR200_bib38","doi-asserted-by":"crossref","first-page":"462","DOI":"10.1111\/j.1365-2133.2004.05844.x","article-title":"Expression and function of peroxisome proliferator-activated receptors in human melanocytes","volume":"150","author":"Kang","year":"2004","journal-title":"Br. J. Dermatol."},{"key":"10.1194\/jlr.R800001-JLR200_bib39","doi-asserted-by":"crossref","first-page":"16390","DOI":"10.1074\/jbc.M000953200","article-title":"The acute phase response is associated with retinoid X receptor repression in rodent liver","volume":"275","author":"Beigneux","year":"2000","journal-title":"J. Biol. Chem."},{"key":"10.1194\/jlr.R800001-JLR200_bib40","first-page":"E201","article-title":"Altered expression of nuclear hormone receptors and coactivators in mouse heart during the acute-phase response","volume":"286","author":"Feingold","year":"2004","journal-title":"Am. J. Physiol."},{"key":"10.1194\/jlr.R800001-JLR200_bib41","doi-asserted-by":"crossref","first-page":"2179","DOI":"10.1194\/jlr.M500540-JLR200","article-title":"Type II nuclear hormone receptors, coactivator, and target gene repression in adipose tissue in the acute-phase response","volume":"47","author":"Lu","year":"2006","journal-title":"J. Lipid Res."},{"key":"10.1194\/jlr.R800001-JLR200_bib42","doi-asserted-by":"crossref","first-page":"3263","DOI":"10.1101\/gad.207501","article-title":"Critical roles of PPAR beta\/delta in keratinocyte response to inflammation","volume":"15","author":"Tan","year":"2001","journal-title":"Genes Dev."},{"key":"10.1194\/jlr.R800001-JLR200_bib43","doi-asserted-by":"crossref","first-page":"971","DOI":"10.1111\/j.0022-202X.2004.22412.x","article-title":"Peroxisome proliferator-activated receptor (PPAR)-beta\/delta stimulates differentiation and lipid accumulation in keratinocytes","volume":"122","author":"Schmuth","year":"2004","journal-title":"J. Invest. Dermatol."},{"key":"10.1194\/jlr.R800001-JLR200_bib44","doi-asserted-by":"crossref","first-page":"1104","DOI":"10.1046\/j.1523-1747.2003.12536.x","article-title":"Expression and localization of peroxisome proliferator-activated receptors and nuclear factor kappaB in normal and lesional psoriatic skin","volume":"121","author":"Westergaard","year":"2003","journal-title":"J. Invest. Dermatol."},{"key":"10.1194\/jlr.R800001-JLR200_bib45","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1111\/j.1600-0625.2006.00504.x","article-title":"Early cutaneous gene transcription changes in adult atopic dermatitis and potential clinical implications","volume":"16","author":"Plager","year":"2007","journal-title":"Exp. Dermatol."},{"key":"10.1194\/jlr.R800001-JLR200_bib46","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1124\/mol.104.006353","article-title":"The nuclear receptor peroxisome proliferator-activated receptor-alpha mediates the anti-inflammatory actions of palmitoylethanolamide","volume":"67","author":"Lo Verme","year":"2005","journal-title":"Mol. Pharmacol."},{"key":"10.1194\/jlr.R800001-JLR200_bib47","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1046\/j.0022-202x.2001.01626.x","article-title":"Topical peroxisome proliferator activated receptor-alpha activators reduce inflammation in irritant and allergic contact dermatitis models","volume":"118","author":"Sheu","year":"2002","journal-title":"J. Invest. Dermatol."},{"key":"10.1194\/jlr.R800001-JLR200_bib48","doi-asserted-by":"crossref","first-page":"1430","DOI":"10.1046\/j.0022-202x.2001.01537.x","article-title":"Activators of peroxisome proliferator-activated receptors protect human skin from ultraviolet-B-light-induced inflammation","volume":"117","author":"Kippenberger","year":"2001","journal-title":"J. Invest. Dermatol."},{"key":"10.1194\/jlr.R800001-JLR200_bib49","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1038\/sj.cdd.4401713","article-title":"PPARbeta\/delta selectively induces differentiation and inhibits cell proliferation","volume":"13","author":"Kim","year":"2006","journal-title":"Cell Death Differ."},{"key":"10.1194\/jlr.R800001-JLR200_bib50","doi-asserted-by":"crossref","first-page":"1105","DOI":"10.1093\/carcin\/bgi346","article-title":"Inhibition of chemically induced skin carcinogenesis by sulindac is independent of peroxisome proliferator-activated receptor-beta\/delta (PPARbeta\/delta)","volume":"27","author":"Kim","year":"2006","journal-title":"Carcinogenesis."},{"key":"10.1194\/jlr.R800001-JLR200_bib51","doi-asserted-by":"crossref","unstructured":"Man, M. Q., G. D. Barish, M. Schmuth, D. Crumrine, Y. Barak, S. Chang, Y. Jiang, R. M. Evans, P. M. Elias, and K. R. Feingold. 2007. Deficiency of PPARbeta\/delta in the epidermis results in defective cutaneous permeability barrier homeostasis and increased inflammation. J. Invest. Dermatol. In press.","DOI":"10.1038\/sj.jid.5701026"},{"key":"10.1194\/jlr.R800001-JLR200_bib52","doi-asserted-by":"crossref","first-page":"5119","DOI":"10.1128\/MCB.20.14.5119-5128.2000","article-title":"Growth, adipose, brain, and skin alterations resulting from targeted disruption of the mouse peroxisome proliferator-activated receptor beta(delta)","volume":"20","author":"Peters","year":"2000","journal-title":"Mol. Cell. Biol."},{"key":"10.1194\/jlr.R800001-JLR200_bib53","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1111\/j.0022-202X.2004.23235.x","article-title":"Peroxisome-proliferator-activated receptor (PPAR)-gamma activation stimulates keratinocyte differentiation","volume":"123","author":"Mao-Qiang","year":"2004","journal-title":"J. Invest. Dermatol."},{"key":"10.1194\/jlr.R800001-JLR200_bib54","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1038\/83336","article-title":"PPAR-gamma dependent and independent effects on macrophage-gene expression in lipid metabolism and inflammation","volume":"7","author":"Chawla","year":"2001","journal-title":"Nat. Med."},{"key":"10.1194\/jlr.R800001-JLR200_bib55","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1046\/j.1523-1747.2003.12033.x","article-title":"Liver X receptor activators display anti-inflammatory activity in irritant and allergic contact dermatitis models: liver-X-receptor-specific inhibition of inflammation and primary cytokine production","volume":"120","author":"Fowler","year":"2003","journal-title":"J. Invest. Dermatol."},{"key":"10.1194\/jlr.R800001-JLR200_bib56","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1038\/nm820","article-title":"Reciprocal regulation of inflammation and lipid metabolism by liver X receptors","volume":"9","author":"Joseph","year":"2003","journal-title":"Nat. Med."},{"key":"10.1194\/jlr.R800001-JLR200_bib57","doi-asserted-by":"crossref","first-page":"1316","DOI":"10.1152\/physrev.1989.69.4.1316","article-title":"Structure, function, and differentiation of the keratinocyte","volume":"69","author":"Eckert","year":"1989","journal-title":"Physiol. Rev."},{"key":"10.1194\/jlr.R800001-JLR200_bib58","doi-asserted-by":"crossref","first-page":"2807","DOI":"10.1083\/jcb.111.6.2807","article-title":"Epidermal differentiation: the bare essentials","volume":"111","author":"Fuchs","year":"1990","journal-title":"J. Cell Biol."},{"key":"10.1194\/jlr.R800001-JLR200_bib59","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1034\/j.1600-0625.2001.110308.x","article-title":"Basis for the permeability barrier abnormality in lamellar ichthyosis","volume":"11","author":"Elias","year":"2002","journal-title":"Exp. Dermatol."},{"key":"10.1194\/jlr.R800001-JLR200_bib60","doi-asserted-by":"crossref","first-page":"909","DOI":"10.1111\/j.0022-202X.2004.22431.x","article-title":"Structural and functional consequences of loricrin mutations in human loricrin keratoderma (Vohwinkel syndrome with ichthyosis)","volume":"122","author":"Schmuth","year":"2004","journal-title":"J. Invest. Dermatol."},{"key":"10.1194\/jlr.R800001-JLR200_bib61","doi-asserted-by":"crossref","first-page":"368","DOI":"10.1046\/j.1523-1747.1998.00139.x","article-title":"Keratinocyte differentiation is stimulated by activators of the nuclear hormone receptor PPARalpha","volume":"110","author":"Hanley","year":"1998","journal-title":"J. Invest. Dermatol."},{"key":"10.1194\/jlr.R800001-JLR200_bib62","doi-asserted-by":"crossref","first-page":"11484","DOI":"10.1074\/jbc.275.15.11484","article-title":"Farnesol stimulates differentiation in epidermal keratinocytes via PPARalpha","volume":"275","author":"Hanley","year":"2000","journal-title":"J. Biol. Chem."},{"key":"10.1194\/jlr.R800001-JLR200_bib63","doi-asserted-by":"crossref","first-page":"17","DOI":"10.2119\/2006-00001.Kim","article-title":"Phytosphingosine stimulates the differentiation of human keratinocytes and inhibits TPA-induced inflammatory epidermal hyperplasia in hairless mouse skin","volume":"12","author":"Kim","year":"2006","journal-title":"Mol. Med."},{"key":"10.1194\/jlr.R800001-JLR200_bib64","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1046\/j.1523-1747.2000.00073.x","article-title":"Stimulation of PPARalpha promotes epidermal keratinocyte differentiation in vivo","volume":"115","author":"Komuves","year":"2000","journal-title":"J. Invest. Dermatol."},{"key":"10.1194\/jlr.R800001-JLR200_bib65","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1111\/j.0906-6705.2005.00386.x","article-title":"Phytocomponents of triterpenoids, oleanolic acid and ursolic acid, regulated differently the processing of epidermal keratinocytes via PPAR-alpha pathway","volume":"15","author":"Lee","year":"2006","journal-title":"Exp. Dermatol."},{"key":"10.1194\/jlr.R800001-JLR200_bib66","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1111\/j.1346-8138.2007.00344.x","article-title":"Simultaneous effect of ursolic acid and oleanolic acid on epidermal permeability barrier function and epidermal keratinocyte differentiation via peroxisome proliferator-activated receptor-alpha","volume":"34","author":"Lim","year":"2007","journal-title":"J. Dermatol."},{"key":"10.1194\/jlr.R800001-JLR200_bib67","doi-asserted-by":"crossref","first-page":"901","DOI":"10.1042\/bj20020377","article-title":"Inhibition of peroxisome proliferator-activated receptor (PPAR)-mediated keratinocyte differentiation by lipoxygenase inhibitors","volume":"366","author":"Thuillier","year":"2002","journal-title":"Biochem. J."},{"key":"10.1194\/jlr.R800001-JLR200_bib68","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1046\/j.1523-1747.2000.00895.x","article-title":"Oxysterols induce differentiation in human keratinocytes and increase Ap-1-dependent involucrin transcription","volume":"114","author":"Hanley","year":"2000","journal-title":"J. Invest. Dermatol."},{"key":"10.1194\/jlr.R800001-JLR200_bib69","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1111\/j.0022-202X.2004.22707.x","article-title":"The effect of LXR activators on AP-1 proteins in keratinocytes","volume":"123","author":"Schmuth","year":"2004","journal-title":"J. Invest. Dermatol."},{"key":"10.1194\/jlr.R800001-JLR200_bib70","doi-asserted-by":"crossref","first-page":"42268","DOI":"10.1074\/jbc.M205593200","article-title":"Loricrin expression in cultured human keratinocytes is controlled by a complex interplay between transcription factors of the Sp1, CREB, AP1, and AP2 families","volume":"277","author":"Jang","year":"2002","journal-title":"J. Biol. Chem."},{"key":"10.1194\/jlr.R800001-JLR200_bib71","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/S0378-1119(00)00291-2","article-title":"Functional AP1 and CRE response elements in the human keratinocyte transglutaminase promoter mediating Whn suppression","volume":"254","author":"Jessen","year":"2000","journal-title":"Gene."},{"key":"10.1194\/jlr.R800001-JLR200_bib72","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1046\/j.1523-1747.1998.00071.x","article-title":"Effect of AP1 transcription factors on the regulation of transcription in normal human epidermal keratinocytes","volume":"110","author":"Rossi","year":"1998","journal-title":"J. Invest. Dermatol."},{"key":"10.1194\/jlr.R800001-JLR200_bib73","doi-asserted-by":"crossref","first-page":"1728","DOI":"10.1038\/sj.jid.5700758","article-title":"STAT5a\/PPARgamma pathway regulates involucrin expression in keratinocyte differentiation","volume":"127","author":"Dai","year":"2007","journal-title":"J. Invest. Dermatol."},{"key":"10.1194\/jlr.R800001-JLR200_bib74","doi-asserted-by":"crossref","first-page":"842","DOI":"10.1038\/sj.cdd.4401036","article-title":"Jagged-1 mediated activation of notch signaling induces complete maturation of human keratinocytes through NF-kappaB and PPARgamma","volume":"9","author":"Nickoloff","year":"2002","journal-title":"Cell Death Differ."},{"key":"10.1194\/jlr.R800001-JLR200_bib75","doi-asserted-by":"crossref","first-page":"2531","DOI":"10.1194\/jlr.R700013-JLR200","article-title":"Thematic review series: skin lipids. The role of epidermal lipids in cutaneous permeability barrier homeostasis","volume":"48","author":"Feingold","year":"2007","journal-title":"J. Lipid Res."},{"key":"10.1194\/jlr.R800001-JLR200_bib76","doi-asserted-by":"crossref","first-page":"386","DOI":"10.1038\/sj.jid.5700046","article-title":"Basis for improved permeability barrier homeostasis induced by PPAR and LXR activators: liposensors stimulate lipid synthesis, lamellar body secretion, and post-secretory lipid processing","volume":"126","author":"Man","year":"2006","journal-title":"J. Invest. Dermatol."},{"key":"10.1194\/jlr.R800001-JLR200_bib77","doi-asserted-by":"crossref","first-page":"1525","DOI":"10.1101\/gad.368706","article-title":"Genetic and pharmacological evidence that a retinoic acid cannot be the RXR-activating ligand in mouse epidermis keratinocytes","volume":"20","author":"Calleja","year":"2006","journal-title":"Genes Dev."},{"key":"10.1194\/jlr.R800001-JLR200_bib78","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1046\/j.1523-1747.2000.00939.x","article-title":"Peroxisome proliferator-activated receptor-alpha enhances lipid metabolism in a skin equivalent model","volume":"114","author":"Rivier","year":"2000","journal-title":"J. Invest. Dermatol."},{"key":"10.1194\/jlr.R800001-JLR200_bib79","doi-asserted-by":"crossref","first-page":"1708","DOI":"10.1172\/JCI25736","article-title":"Harlequin ichthyosis unmasked: a defect of lipid transport","volume":"115","author":"Hovnanian","year":"2005","journal-title":"J. Clin. Invest."},{"key":"10.1194\/jlr.R800001-JLR200_bib80","doi-asserted-by":"crossref","first-page":"1777","DOI":"10.1172\/JCI24834","article-title":"Mutations in lipid transporter ABCA12 in harlequin ichthyosis and functional recovery by corrective gene transfer","volume":"115","author":"Akiyama","year":"2005","journal-title":"J. Clin. Invest."},{"key":"10.1194\/jlr.R800001-JLR200_bib81","doi-asserted-by":"crossref","first-page":"794","DOI":"10.1086\/429844","article-title":"Mutations in ABCA12 underlie the severe congenital skin disease harlequin ichthyosis","volume":"76","author":"Kelsell","year":"2005","journal-title":"Am. J. Hum. Genet."},{"key":"10.1194\/jlr.R800001-JLR200_bib82","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1038\/sj.jid.5700944","article-title":"PPAR and LXR activators regulate ABCA12 expression in human keratinocytes","volume":"128","author":"Jiang","year":"2008","journal-title":"J. Invest. Dermatol."},{"key":"10.1194\/jlr.R800001-JLR200_bib83","doi-asserted-by":"crossref","first-page":"1656","DOI":"10.1172\/JCI116374","article-title":"Processing of epidermal glucosylceramides is required for optimal mammalian cutaneous permeability barrier function","volume":"91","author":"Holleran","year":"1993","journal-title":"J. Clin. Invest."},{"key":"10.1194\/jlr.R800001-JLR200_bib84","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1046\/j.1523-1747.2003.22258.x","article-title":"Basis for abnormal desquamation and permeability barrier dysfunction in RXLI","volume":"122","author":"Elias","year":"2004","journal-title":"J. Invest. Dermatol."},{"key":"10.1194\/jlr.R800001-JLR200_bib85","doi-asserted-by":"crossref","first-page":"1268","DOI":"10.1194\/jlr.R300005-JLR200","article-title":"Cholesterol sulfate in human physiology: what's it all about?","volume":"44","author":"Strott","year":"2003","journal-title":"J. Lipid Res."},{"key":"10.1194\/jlr.R800001-JLR200_bib86","doi-asserted-by":"crossref","first-page":"2657","DOI":"10.1194\/jlr.M500235-JLR200","article-title":"LXR and PPAR activators stimulate cholesterol sulfotransferase type 2 isoform 1b in human keratinocytes","volume":"46","author":"Jiang","year":"2005","journal-title":"J. Lipid Res."},{"key":"10.1194\/jlr.R800001-JLR200_bib87","doi-asserted-by":"crossref","first-page":"2248","DOI":"10.1194\/jlr.M600163-JLR200","article-title":"Regulation of ABCA1 expression in human keratinocytes and murine epidermis","volume":"47","author":"Jiang","year":"2006","journal-title":"J. Lipid Res."},{"key":"10.1194\/jlr.R800001-JLR200_bib88","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1172\/JCI119583","article-title":"Activators of the nuclear hormone receptors PPARalpha and FXR accelerate the development of the fetal epidermal permeability barrier","volume":"100","author":"Hanley","year":"1997","journal-title":"J. Clin. Invest."},{"key":"10.1194\/jlr.R800001-JLR200_bib89","doi-asserted-by":"crossref","first-page":"1298","DOI":"10.1046\/j.1523-1747.2002.19605.x","article-title":"Role of peroxisome proliferator-activated receptor alpha in epidermal development in utero","volume":"119","author":"Schmuth","year":"2002","journal-title":"J. Invest. Dermatol."},{"key":"10.1194\/jlr.R800001-JLR200_bib90","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1007\/BF02530090","article-title":"The epidermal hyperplasia associated with repeated barrier disruption by acetone treatment or tape stripping cannot be attributed to increased water loss","volume":"288","author":"Denda","year":"1996","journal-title":"Arch. Dermatol. Res."},{"key":"10.1194\/jlr.R800001-JLR200_bib91","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1046\/j.1523-1747.2000.00076.x","article-title":"Keratinocyte differentiation in hyperproliferative epidermis: topical application of PPARalpha activators restores tissue homeostasis","volume":"115","author":"Komuves","year":"2000","journal-title":"J. Invest. Dermatol."},{"key":"10.1194\/jlr.R800001-JLR200_bib92","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1038\/sj.jid.5700056","article-title":"Alterations in skin and stratified epithelia by constitutively activated PPARalpha","volume":"126","author":"Yang","year":"2006","journal-title":"J. Invest. Dermatol."},{"key":"10.1194\/jlr.R800001-JLR200_bib93","doi-asserted-by":"crossref","first-page":"3012","DOI":"10.1128\/MCB.15.6.3012","article-title":"Targeted disruption of the alpha isoform of the peroxisome proliferator-activated receptor gene in mice results in abolishment of the pleiotropic effects of peroxisome proliferators","volume":"15","author":"Lee","year":"1995","journal-title":"Mol. Cell. Biol."},{"key":"10.1194\/jlr.R800001-JLR200_bib94","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1038\/sj.jid.5700137","article-title":"(P)PARsing epidermal development","volume":"126","author":"Dubrac","year":"2006","journal-title":"J. Invest. Dermatol."},{"key":"10.1194\/jlr.R800001-JLR200_bib95","doi-asserted-by":"crossref","first-page":"1163","DOI":"10.1016\/j.cellsig.2006.12.007","article-title":"Ligand activation of peroxisome proliferator-activated receptor-beta\/delta (PPARbeta\/delta) inhibits cell growth of human N\/TERT-1 keratinocytes","volume":"19","author":"Burdick","year":"2007","journal-title":"Cell. Signal."},{"key":"10.1194\/jlr.R800001-JLR200_bib96","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/j.cellsig.2005.07.009","article-title":"The role of peroxisome proliferator-activated receptor-beta\/delta in epithelial cell growth and differentiation","volume":"18","author":"Burdick","year":"2006","journal-title":"Cell. Signal."},{"key":"10.1194\/jlr.R800001-JLR200_bib97","doi-asserted-by":"crossref","first-page":"9519","DOI":"10.1074\/jbc.M413808200","article-title":"Peroxisome proliferator-activated receptor-beta\/delta inhibits epidermal cell proliferation by down-regulation of kinase activity","volume":"280","author":"Kim","year":"2005","journal-title":"J. Biol. Chem."},{"key":"10.1194\/jlr.R800001-JLR200_bib98","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1080\/15287390500227522","article-title":"Effects of di(2-ethylhexyl) phthalate, a widely used peroxisome proliferator and plasticizer, on cell growth in the human keratinocyte cell line NCTC 2544","volume":"69","author":"Martinasso","year":"2006","journal-title":"J. Toxicol. Environ. Health."},{"key":"10.1194\/jlr.R800001-JLR200_bib99","doi-asserted-by":"crossref","first-page":"721","DOI":"10.1016\/S1097-2765(02)00646-9","article-title":"Antiapoptotic role of PPARbeta in keratinocytes via transcriptional control of the Akt1 signaling pathway","volume":"10","author":"Di-Poi","year":"2002","journal-title":"Mol. Cell."},{"key":"10.1194\/jlr.R800001-JLR200_bib100","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1046\/j.0022-202X.2003.22111.x","article-title":"Rosiglitazone inhibits proliferation, motility, and matrix metalloproteinase production in keratinocytes","volume":"122","author":"Bhagavathula","year":"2004","journal-title":"J. Invest. Dermatol."},{"key":"10.1194\/jlr.R800001-JLR200_bib101","doi-asserted-by":"crossref","first-page":"1110","DOI":"10.1111\/j.0022-202X.2004.23465.x","article-title":"Troglitazone inhibits cyclin D1 expression and cell cycling independently of PPARgamma in normal mouse skin keratinocytes","volume":"123","author":"He","year":"2004","journal-title":"J. Invest. Dermatol."},{"key":"10.1194\/jlr.R800001-JLR200_bib102","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1111\/j.1600-0625.2006.00402.x","article-title":"Topical treatment with thiazolidinediones, activators of peroxisome proliferator-activated receptor-gamma, normalizes epidermal homeostasis in a murine hyperproliferative disease model","volume":"15","author":"Demerjian","year":"2006","journal-title":"Exp. Dermatol."},{"key":"10.1194\/jlr.R800001-JLR200_bib103","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1002\/1098-2744(200011)29:3<134::AID-MC2>3.0.CO;2-F","article-title":"Activators of peroxisome proliferator-activated receptor-alpha partially inhibit mouse skin tumor promotion","volume":"29","author":"Thuillier","year":"2000","journal-title":"Mol. Carcinog."},{"key":"10.1194\/jlr.R800001-JLR200_bib104","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1093\/carcin\/20.2.249","article-title":"Fish oil constituent docosahexaenoic acid selectively inhibits growth of human papillomavirus immortalized keratinocytes","volume":"20","author":"Chen","year":"1999","journal-title":"Carcinogenesis."},{"key":"10.1194\/jlr.R800001-JLR200_bib105","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1002\/mc.20111","article-title":"The effect of PPARgamma ligands on UV- or chemically-induced carcinogenesis in mouse skin","volume":"43","author":"He","year":"2005","journal-title":"Mol. Carcinog."},{"key":"10.1194\/jlr.R800001-JLR200_bib106","doi-asserted-by":"crossref","first-page":"1747","DOI":"10.1093\/carcin\/bgh160","article-title":"PPARgamma influences susceptibility to DMBA-induced mammary, ovarian and skin carcinogenesis","volume":"25","author":"Nicol","year":"2004","journal-title":"Carcinogenesis."},{"key":"10.1194\/jlr.R800001-JLR200_bib107","doi-asserted-by":"crossref","first-page":"1253","DOI":"10.1001\/archotol.127.10.1253","article-title":"Correlation of expression of cyclooxygenase-2, vascular endothelial growth factor, and peroxisome proliferator-activated receptor delta with head and neck squamous cell carcinoma","volume":"127","author":"Jaeckel","year":"2001","journal-title":"Arch. Otolaryngol. Head Neck Surg."},{"key":"10.1194\/jlr.R800001-JLR200_bib108","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1111\/j.0303-6987.2005.00345.x","article-title":"Peroxisome proliferator-activated receptors in squamous cell carcinoma and its precursors","volume":"32","author":"Nijsten","year":"2005","journal-title":"J. Cutan. Pathol."},{"key":"10.1194\/jlr.R800001-JLR200_bib109","doi-asserted-by":"crossref","first-page":"576","DOI":"10.1046\/j.1523-1747.2002.01861.x","article-title":"Agonists of peroxisome proliferator-activated receptor gamma inhibit cell growth in malignant melanoma","volume":"119","author":"Mossner","year":"2002","journal-title":"J. Invest. Dermatol."},{"key":"10.1194\/jlr.R800001-JLR200_bib110","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1016\/j.canlet.2006.02.022","article-title":"Variations in the peroxisome proliferator-activated receptor-gamma gene and melanoma risk","volume":"246","author":"Mossner","year":"2007","journal-title":"Cancer Lett."},{"key":"10.1194\/jlr.R800001-JLR200_bib111","doi-asserted-by":"crossref","first-page":"3686","DOI":"10.1038\/sj.emboj.7601803","article-title":"Deregulation of tumor angiogenesis and blockade of tumor growth in PPARbeta-deficient mice","volume":"26","author":"Muller-Brusselbach","year":"2007","journal-title":"EMBO J."},{"key":"10.1194\/jlr.R800001-JLR200_bib112","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1111\/j.0022-202X.2004.23207.x","article-title":"The novel synthetic oleanane triterpenoid CDDO (2-cyano-3,12-dioxoolean-1,9-dien-28-oic acid) induces apoptosis in mycosis fungoides\/Sezary syndrome cells","volume":"123","author":"Zhang","year":"2004","journal-title":"J. Invest. Dermatol."},{"key":"10.1194\/jlr.R800001-JLR200_bib113","doi-asserted-by":"crossref","first-page":"386","DOI":"10.1111\/j.1540-9740.2005.04434.x","article-title":"Improvement in psoriasis with rosiglitazone in a diabetic and a nondiabetic patient","volume":"4","author":"Pershadsingh","year":"2005","journal-title":"Skinmed."},{"key":"10.1194\/jlr.R800001-JLR200_bib114","doi-asserted-by":"crossref","first-page":"93","DOI":"10.2165\/00128071-200708020-00005","article-title":"Placebo response in two long-term randomized psoriasis studies that were negative for rosiglitazone","volume":"8","author":"Ellis","year":"2007","journal-title":"Am. J. Clin. Dermatol."},{"key":"10.1194\/jlr.R800001-JLR200_bib115","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1111\/j.1365-4632.2005.02504.x","article-title":"Pilot trial: pioglitazone versus placebo in patients with plaque psoriasis (the P6)","volume":"44","author":"Shafiq","year":"2005","journal-title":"Int. J. Dermatol."},{"key":"10.1194\/jlr.R800001-JLR200_bib116","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1159\/000068897","article-title":"Effect of topical PPARbeta\/delta and PPARgamma agonists on plaque psoriasis. A pilot study","volume":"206","author":"Kuenzli","year":"2003","journal-title":"Dermatology."},{"key":"10.1194\/jlr.R800001-JLR200_bib117","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1046\/j.1365-2133.2003.05532.x","article-title":"Peroxisome proliferator-activated receptors in cutaneous biology","volume":"149","author":"Kuenzli","year":"2003","journal-title":"Br. J. Dermatol."},{"key":"10.1194\/jlr.R800001-JLR200_bib118","doi-asserted-by":"crossref","first-page":"205","DOI":"10.2174\/1568010043343976","article-title":"Peroxisome proliferator-activated receptors as new molecular targets in psoriasis","volume":"3","author":"Kuenzli","year":"2004","journal-title":"Curr. Drug Targets."},{"key":"10.1194\/jlr.R800001-JLR200_bib119","first-page":"AB67","article-title":"New natural PPAR-alpha agonist for childhood atopic dermatitis: dermocorticoid-sparing and quality of life improvement (Abstract)","volume":"56","author":"Msika","year":"2007","journal-title":"J. Am. Acad. Dermatol."}],"container-title":["Journal of Lipid Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022227520424083?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022227520424083?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1194\/jlr.R800001-JLR200","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,11,20]],"date-time":"2021-11-20T18:15:04Z","timestamp":1637432104000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0022227520424083"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,3]]},"references-count":119,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2008,3]]}},"alternative-id":["S0022227520424083"],"URL":"https:\/\/doi.org\/10.1194\/jlr.r800001-jlr200","relation":{},"ISSN":["0022-2275"],"issn-type":[{"value":"0022-2275","type":"print"}],"subject":[],"published":{"date-parts":[[2008,3]]}}}